IMMUNIZATION STRATEGY WITH ALVAC-HIV VCP1452 IN HIV-1 SUBJECTS

HIV-1 受试者中 ALVAC-HIV VCP1452 的免疫策略

• 批准号: 7377418
• 负责人: Joseph J Eron
• 金额: $ 2.01万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7377418
• 关键词: IMMUNIZATION; STRATEGY; ALVAC; HIV; VCP1452

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this research study is to see if either stopping anti-HIV drugs for short periods of time or adding a vaccine to the anti-HIV drugs already being taken will help to better control HIV infection. The study will check to see if the vaccine is safe to use in people with HIV infection. The study will also check to see if stopping anti-HIV medicines for short periods of time is safe.

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者（PI）可能从另一个NIH来源获得主要资金，因此可以在其他CRISP条目中表示。所列机构为中心，不一定是研究者所在机构。这项研究的目的是看看短期停止抗艾滋病毒药物或在已经服用的抗艾滋病毒药物中添加疫苗是否有助于更好地控制艾滋病毒感染。这项研究将检查该疫苗是否安全用于艾滋病毒感染者。该研究还将检查短期停止抗艾滋病毒药物是否安全。